Solid Biosciences (SLDB) stock surges after strong Phase 1/2 data for its Duchenne therapy SGT-003. Read more here.
7h
Hosted on MSNBio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions ...
Bell Potter analyst Martyn Jacobs maintained a Buy rating on Biome Australia Ltd (BIO – Research Report) today and set a price target of ...
Adicet Bio, Inc. (NASDAQ:ACET), currently trading at $0.99 with a market capitalization of $81.7 million, is a clinical-stage biopharmaceutical company focused on developing novel cell therapies based ...
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that ...
INmune Bio (NASDAQ:INMB – Get Free Report) had its price target hoisted by investment analysts at Maxim Group from $22.00 to $30.00 in a research note issued to investors on Thursday,Benzinga reports.
RBC Capital lowered the firm’s price target on Bio-Rad (BIO) to $447 from $477 and keeps an Outperform rating on the shares. The company ...
We recently compiled a list of the 10 Micro and Small-Cap Firms Drive Year-to-Date Gains. In this article, we are going to take a look at where Rapid Micro Biosystems, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results